Mycosis fungoides-type cutaneous T-cell lymphoma and neutrophilic dermatosis

Archives of Dermatology

Volumn 141, Issue 3, 2005, Pages 353-356

  Franck, Nathalie ^a   Carlotti, Agnes ^a   Gorin, Isabelle ^a   Buffet, Marc ^a   Mateus, Christine ^a   Dupin, Nicolas ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CHLORMETHINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETRETIN; INDOMETACIN; ISOTRETINOIN; METHOTREXATE; PENTOSTATIN; PREDNISONE; PSORALEN; THALIDOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELECTRON BEAM; EXPERIENCE; FATALITY; HUMAN; MALE; MYCOSIS FUNGOIDES; NEUTROPHILIC DERMATOSIS; OUTCOMES RESEARCH; PAIN; PRIORITY JOURNAL; PROGNOSIS; PUVA; QUALITY OF LIFE; SKIN DEFECT; SKIN DISEASE; SYMPTOM;

EID: 14944378166     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.3.353     Document Type: Article

References (19)

1. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas. Blood. 1997;90:354-371.
2. Bunn PA Jr, Lamberg S. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979;63:725-728.
3. Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome. Arch Dermatol. 2003;139:857-866.
4. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides. Arch Dermatol. 1996;132:1309-1313.
5. Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Transformation of mycosis fungoides/Sézary syndrome. Blood. 1998;92:1150-1159.
6. Vergier B, de Muret A, Beylot-Barry M, et al; French Study Group of Cutaneous Lymphomas. Transformation of mycosis fungoides. Blood. 2000;95:2212-2218.
7. van Doorn R, Scheffer E, Willemze R; Dutch Cutaneous Lymphoma Group. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis. Arch Dermatol. 2002;138:191-198.
8. Hensley CD, Caughman SW. Neutrophilic dermatosis associated with hematologic disorders. Clin Dermatol. 2000;18:355-367.
9. Poszepczynska E, Martinvalet D, Bouloc A, et al. Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis. Br J Dermatol. 2001;144:1073-1079.
10. Aubin F, Dufour MP, Angonin R, Misery L, Laurent R, Humbert P. Sweet's syndrome associated with cutaneous T cell lymphoma. Eur J Dermatol. 1998;8:178-179.
11. Delfau-Larue MH, Dalac S, Lepage E, et al. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood. 1998;92:3376-3380.
12. Cohen PR, Kurzrock R. Sweet's syndrome. Clin Dermatol. 2000;18:265-282.
13. Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol. 2000;18:283-293.
14. Tensen CP, Vermerr MH, van der Stoop PM, et al. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol. 1998;111:222-226.
15. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf. 1994;10:115-150.
16. Wolfe JT, Singh A, Lessin SR, Jaworshy C, Rook AH. De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma. J Am Acad Dermatol. 1995;32:887-893.
17. Taylor C, Burns DA, Wiselka MJ. Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J. 2000;76:365-367.
18. Montoto S, Bosch F, Estrach T, Blade J, Nomdedeu B, Nontserrat E. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma. 1998;30:199-202.
19. Corssmit EP, Heijligenberg R, Hack CE, Endert E, Sauerwein HP, Romijn JA. Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol. 1997;107:359-363.